Customer service isn’t so nice as of late: It’s dismal to fly on most US airways and it’s demoralizing to store in many US supermarkets.

But as I’ve not too long ago found, there’s a notable exception to this sad pattern, and that would be Pot Inc.

I know — it’s exhausting to believe an trade devoted to serving to folks get stoned cares about anything apart from promoting the next joint.

The actuality, however, is that this is a $50 billion trade that is only going to get larger now that the feds made it a Schedule 3 drug that can be prescribed by medical doctors. Yes, it’s about more than just getting excessive. (It helps handle most cancers signs, for one.)

Keep in thoughts, I’m a 64-year-old man whose politics lean to the proper. I hate the odor of hashish — and particularly the truth that it seems to comply with me wherever I stroll in NYC as of late. I work out religiously and am skeptical of all medicine; the last factor I’m doing is placing smoke in my lungs.

I also came to perceive that Pot Inc. isn’t a one-size-fits-all enterprise: There’s gummies if you don’t like to smoke, ointments for muscle ache and, as I talked about, most cancers sufferers see advantages from its utilization. Plus, there’s much about the corporations at the high of the hashish infrastructure that can train company America a factor or two about serving purchasers.

More From Charles Gasparino

Service first

I reached this conclusion from some firsthand expertise when I not too long ago visited a dispensary in Connecticut. A good woman behind a desk checked my ID before I was ushered into a well-appointed showroom. It couldn’t have been more skilled and seamless.

Then last week, I visited the cultivation operations of a firm called Glass House Brands, one of the largest pot corporations in the nation. It just listed its inventory on the NYSE under the image GLAS.

Its farm is positioned in Camarillo, Calif., about 50 miles north of Los Angeles, a place recognized for wealthy soil that’s excellent for rising produce and, as it turns out, weed.

My tour information was a 49-year-old Gen X’er named Graham Farrar, the firm’s president. On paper, Farrar seems like an unlikely candidate to be main the cost on the mainstreaming of pot. He comes from a tech background and farming wasn’t on his résumé until comparatively not too long ago.

In truth, the first factor I seen when we met is that Farrar is constructed like an athlete, not the stereotypical stoner.

“I’ve been using it since I was in junior high school,” Farrar says, and he’s a scholar of pot in all its numerous types. “Though never did I think when I was hanging with my friends I would be running a place like this.”

“This” being the farm where his product is grown. Clad in a T-shirt, denims and work boots, he walked me through all of it — six of the most huge greenhouses I’ve ever seen across 165 acres.

“Each greenhouse is roughly the width of two football fields and the length of eight,” he says, pointing to a row upon row of numerous varieties of weed, including something called “black garlic ­gelato.”

Farrar admits smoking a joint comes with dangers — it’s smoke, after all. But he believes science is on his aspect. “Every study shows it’s better than the alternative,” he says. “If you don’t like smoking it, there are edibles that get you buzzed without the alcohol aftereffects.”

Solar energy

Glass House is also at the tip of the spear for its medicinal makes use of — the acknowledged purpose for President Trump’s current reclassification, he tells me.

Recall how the AI debate has grown more heated as rural communities are getting hosed with increased utility payments as native assets like water and electrical energy get sucked up by information facilities. The Glass House facility, meanwhile, is powered partly by photo voltaic panels and reusable vitality.

“We grow about 330 sunny days a year here, unlike indoor growers paying to run lights on grid power,” Farrar provides. “Most of our power comes from three on-site natural gas cogeneration plants. We use their heat to warm the greenhouses and feed the CO2 to the plants. We have our own water supply and don’t rely on a third-party water supply.”

I remind him I’m skeptical about marijuana for heaps of causes, most of all well being issues. The market seems to be as properly. Shares of GLAS have nosedived more than 80% since its debut on the NYSE in July and more than 50% over the previous 5 years.

Farrar gives me the bull case. Most states already think about it authorized. The reclassification is a large step toward 100% federal legalization because there’s bipartisan support, which means more banking companies will be out there to growers.

Increased legalization creates regulation to preserve the youngsters away. Plus, the public loves the stuff.

“People want cannabis, and the politicians know this,” he provides.